Annual EBITDA
-$84.47 M
-$15.13 M-21.82%
December 31, 2023
Summary
- As of February 8, 2025, IOBT annual EBITDA is -$84.47 million, with the most recent change of -$15.13 million (-21.82%) on December 31, 2023.
- During the last 3 years, IOBT annual EBITDA has fallen by -$72.46 million (-603.02%).
- IOBT annual EBITDA is now -686.77% below its all-time high of -$10.74 million, reached on December 31, 2019.
Performance
IOBT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$26.30 M
-$4.98 M-23.36%
September 30, 2024
Summary
- As of February 8, 2025, IOBT quarterly EBITDA is -$26.30 million, with the most recent change of -$4.98 million (-23.36%) on September 30, 2024.
- Over the past year, IOBT quarterly EBITDA has dropped by -$6.31 million (-31.59%).
- IOBT quarterly EBITDA is now -934.17% below its all-time high of -$2.54 million, reached on December 31, 2020.
Performance
IOBT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$89.37 M
-$3.01 M-3.48%
September 30, 2024
Summary
- As of February 8, 2025, IOBT TTM EBITDA is -$89.37 million, with the most recent change of -$3.01 million (-3.48%) on September 30, 2024.
- Over the past year, IOBT TTM EBITDA has dropped by -$2.66 million (-3.07%).
- IOBT TTM EBITDA is now -2467.48% below its all-time high of -$3.48 million, reached on September 30, 2020.
Performance
IOBT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
IOBT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -21.8% | -31.6% | -3.1% |
| 3 y3 years | -603.0% | -31.6% | -3.1% |
| 5 y5 years | -686.8% | -31.6% | -3.1% |
IOBT EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -25.2% | at low | -71.0% | at low | -47.6% | at low |
| 5 y | 5-year | -686.8% | at low | -934.2% | +31.3% | -2467.5% | at low |
| alltime | all time | -686.8% | at low | -934.2% | +31.3% | -2467.5% | at low |
IO Biotech EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$26.30 M(+23.4%) | -$89.37 M(+3.5%) |
| Jun 2024 | - | -$21.32 M(+6.7%) | -$86.36 M(-0.4%) |
| Mar 2024 | - | -$19.99 M(-8.2%) | -$86.71 M(+2.6%) |
| Dec 2023 | -$84.47 M(+21.8%) | -$21.77 M(-6.5%) | -$84.47 M(+3.5%) |
| Sep 2023 | - | -$23.29 M(+7.5%) | -$81.60 M(+10.7%) |
| Jun 2023 | - | -$21.66 M(+22.1%) | -$73.69 M(+4.8%) |
| Mar 2023 | - | -$17.75 M(-6.1%) | -$70.30 M(+1.4%) |
| Dec 2022 | -$69.34 M | -$18.90 M(+22.9%) | -$69.35 M(-3.1%) |
| Sep 2022 | - | -$15.38 M(-15.9%) | -$71.54 M(+18.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$18.28 M(+8.8%) | -$60.56 M(-24.8%) |
| Mar 2022 | - | -$16.80 M(-20.4%) | -$80.56 M(+19.5%) |
| Dec 2021 | -$67.45 M(+461.3%) | -$21.09 M(+379.8%) | -$67.45 M(+37.9%) |
| Sep 2021 | - | -$4.39 M(-88.5%) | -$48.90 M(+1.9%) |
| Jun 2021 | - | -$38.29 M(+941.5%) | -$47.99 M(+394.7%) |
| Mar 2021 | - | -$3.68 M(+44.6%) | -$9.70 M(+61.0%) |
| Dec 2020 | -$12.02 M(+11.9%) | -$2.54 M(-26.9%) | -$6.02 M(+73.1%) |
| Sep 2020 | - | -$3.48 M | -$3.48 M |
| Dec 2019 | -$10.74 M | - | - |
FAQ
- What is IO Biotech annual EBITDA?
- What is the all time high annual EBITDA for IO Biotech?
- What is IO Biotech annual EBITDA year-on-year change?
- What is IO Biotech quarterly EBITDA?
- What is the all time high quarterly EBITDA for IO Biotech?
- What is IO Biotech quarterly EBITDA year-on-year change?
- What is IO Biotech TTM EBITDA?
- What is the all time high TTM EBITDA for IO Biotech?
- What is IO Biotech TTM EBITDA year-on-year change?
What is IO Biotech annual EBITDA?
The current annual EBITDA of IOBT is -$84.47 M
What is the all time high annual EBITDA for IO Biotech?
IO Biotech all-time high annual EBITDA is -$10.74 M
What is IO Biotech annual EBITDA year-on-year change?
Over the past year, IOBT annual EBITDA has changed by -$15.13 M (-21.82%)
What is IO Biotech quarterly EBITDA?
The current quarterly EBITDA of IOBT is -$26.30 M
What is the all time high quarterly EBITDA for IO Biotech?
IO Biotech all-time high quarterly EBITDA is -$2.54 M
What is IO Biotech quarterly EBITDA year-on-year change?
Over the past year, IOBT quarterly EBITDA has changed by -$6.31 M (-31.59%)
What is IO Biotech TTM EBITDA?
The current TTM EBITDA of IOBT is -$89.37 M
What is the all time high TTM EBITDA for IO Biotech?
IO Biotech all-time high TTM EBITDA is -$3.48 M
What is IO Biotech TTM EBITDA year-on-year change?
Over the past year, IOBT TTM EBITDA has changed by -$2.66 M (-3.07%)